1. Home
  2. PLAB vs TYRA Comparison

PLAB vs TYRA Comparison

Compare PLAB & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$50.50

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$37.04

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
TYRA
Founded
1969
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PLAB
TYRA
Price
$50.50
$37.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$44.33
$47.50
AVG Volume (30 Days)
718.5K
831.8K
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
N/A
EPS
0.74
N/A
Revenue
$535,276,000.00
N/A
Revenue This Year
$6.70
N/A
Revenue Next Year
$4.96
N/A
P/E Ratio
$70.41
N/A
Revenue Growth
18.77
N/A
52 Week Low
$16.59
$8.75
52 Week High
$56.00
$40.65

Technical Indicators

Market Signals
Indicator
PLAB
TYRA
Relative Strength Index (RSI) 54.52 57.77
Support Level $46.18 $33.81
Resistance Level $52.79 $39.48
Average True Range (ATR) 2.38 2.18
MACD -0.36 0.28
Stochastic Oscillator 43.99 77.39

Price Performance

Historical Comparison
PLAB
TYRA

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: